Skip to main content
Livermore
Livermore
ZHEN

Esperion Therapeutics, Inc.

ESPRDelisted Jul 13, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001434868

Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.

Holders of 5% or more of ESPR

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Esperion Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ESPR
HolderLatest formStakeChangeFirst filedLatest filingFiling
Glazer Capital, LLC13G8.15%21.0M sharesNewJun 8, 20261 filingJun 8, 2026SEC
Goldman Sachs Group Inc13G6.70%17.2M sharesNewAug 13, 20261 filingAug 13, 2026SEC
Vanguard Capital Management LLC13G5.08%13.1M sharesNewJul 31, 20261 filingJul 31, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

68 Schedule 13D and 13G filings on Esperion Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ESPR
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 9, 2022State Street Corp13G/AOld format–––SEC
Jan 12, 2022Meditor Group Ltd13G/AOld format–––SEC
Jan 10, 202212:54 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 5, 2022Sabby Management, LLC13G/AOld format–––SEC
Dec 10, 2021CVI Investments, Inc.13GOld format–New–SEC
Dec 9, 2021Sabby Management, LLC13GOld format–New–SEC
Dec 9, 2021Deep Track Capital, LP13GOld format–New–SEC
Dec 7, 2021Flynn James E13GOld format–New–SEC
May 28, 2021BB Biotech AG13G/AOld format–––SEC
Feb 16, 2021Pentwater Capital Management LP13G/AOld format–––SEC
Feb 16, 2021Marshall Wace, LLP13G/AOld format–––SEC
Feb 12, 2021Platinum Investment Management Ltd13GOld format–New–SEC
Feb 12, 2021BB Biotech AG13G/AOld format–––SEC
Feb 11, 2021State Street Corp13GOld format–New–SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2021Wasatch Advisors Inc13G/AOld format–––SEC
Feb 5, 20217:51 AM ETBlackRock Inc.13G/AOld format–––SEC
Jan 6, 2021Meditor Group Ltd13G/AOld format–––SEC

Form 144: proposed insider sales

10 notices from officers, directors and other affiliates planning to sell Esperion Therapeutics, Inc. shares, newest first.

Form 144 notices for ESPR
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Sep 20, 20233:22 PM ETWarren EricOfficer742$924.01Sep 20, 2023Fidelity Brokerage Services LLCSEC
Aug 18, 20233:31 PM ETWarren EricOfficer243$343.67Aug 18, 2023Fidelity Brokerage Services LLCSEC
Jul 19, 20233:32 PM ETWarren EricOfficer106$168.01Jul 19, 2023Fidelity Brokerage Services LLCSEC
Jun 21, 20233:24 PM ETWarren EricOfficer603$894.13Jun 21, 2023Fidelity Brokerage Services LLCSEC
May 17, 20234:40 PM ETWarren EricOfficer219$355.57May 17, 2023Fidelity Brokerage Services LLCSEC
Apr 19, 20234:13 PM ETAmendedWarren EricOfficer115$147.02Apr 19, 2023Fidelity Brokerage Services LLCSEC
Apr 19, 20233:24 PM ETLooker BenjaminOfficer1.29K$1.64KApr 19, 2023Fidelity Brokerage Services LLCSEC
Apr 19, 20233:22 PM ETFoody Joanne M.Officer938$1.19KApr 19, 2023Fidelity Brokerage Services LLCSEC
Mar 17, 20233:45 PM ETKoenig Sheldon L.Officer · Director7.00K$12.5KMar 17, 2023Fidelity Brokerage Services LLCSEC
Mar 7, 20233:31 PM ETKoenig Sheldon L.Officer5.44K$27.5KMar 7, 2023Fidelity Brokerage Services LLCSEC